AIM
ABBV icon

Advantage Investment Management’s AbbVie ABBV Stock Holding History

Advantage Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$353K Buy
4,655
+905
+24% +$62K 0.28% 66
2019
Q2 		$273K Buy
3,750
+536
+17% +$42.1K 0.21% 104
2019
Q1 		$259K Sell
3,214
-7
-0.2% -$573 0.2% 102
2018
Q4 		$297K Buy
3,221
+157
+5% +$13.8K 0.22% 80
2018
Q3 		$290K Buy
3,064
+235
+8% +$22.3K 0.19% 95
2018
Q2 		$262K Hold
2,829
– – 0.19% 98
2018
Q1 		$268K Sell
2,829
-311
-10% -$34.2K 0.1% 138
2017
Q4 		$304K Sell
3,140
-363
-10% -$34.2K 0.09% 135
2017
Q3 		$311K Sell
3,503
-263
-7% -$20K 0.1% 134
2017
Q2 		$273K Sell
3,766
-224
-6% -$15.1K 0.1% 138
2017
Q1 		$260K Sell
3,990
-110
-3% -$6.92K 0.1% 129
2016
Q4 		$257K Sell
4,100
-50
-1% -$3.05K 0.1% 127
2016
Q3 		$262K Buy
4,150
+496
+14% +$32.1K 0.1% 115
2016
Q2 		$226K Sell
3,654
-700
-16% -$42.7K 0.11% 120
2016
Q1 		$249K Buy
4,354
+800
+23% +$44.6K 0.11% 111
2015
Q4 		$211K Buy
3,554
+43
+1% +$2.48K 0.11% 129
2015
Q3 		$191K Buy
3,511
+500
+17% +$32.5K 0.11% 126
2015
Q2 		$202K Sell
3,011
-13
-0.4% -$849 0.1% 139
2015
Q1 		$177K Buy
3,024
+1,268
+72% +$76.6K 0.1% 153
2014
Q4 		$115K Buy
+1,756
New +$111K 0.09% 189

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Advantage Investment Management's ABBV Position: Q3 2019 in Review

Advantage Investment Management increased its AbbVie (ABBV) stake by 24% in Q3 2019, buying an estimated $62K and bringing the position to 4,655 shares worth $353K. The position accounts for 0.28% of the portfolio, ranked #66.

Advantage Investment Management first reported a position in ABBV in Q4 2014 and has held it in 20 quarters since. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Advantage Investment Management held 4,655 shares of AbbVie worth $353K as of Q3 2019.
  • Advantage Investment Management bought 905 AbbVie shares in Q3 2019, an estimated $62K.
  • AbbVie made up 0.28% of Advantage Investment Management's portfolio in Q3 2019, its #66 holding.
  • Advantage Investment Management first reported a position in AbbVie in Q4 2014 and has held it in 20 quarters since.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.